Cytokine adsorption in severe, refractory septic shock
- PMID: 34471938
- PMCID: PMC8409473
- DOI: 10.1007/s00134-021-06512-0
Cytokine adsorption in severe, refractory septic shock
Conflict of interest statement
MM reported receiving research grants from CytoSorbents Europe GmbH (Berlin, Germany) and Baxter International Inc. (Deerfield, USA), as well as personal fees for his work as external consultant from Baxter International Inc. (Deerfield, USA) and Toray Industries Inc. (Tokyo, Japan). All other authors declare no conflicts of interest.
Figures
Comment in
-
Unraveling the secret of re-balancing homeostasis in sepsis: a critical view on extracorporeal blood purification modalities.Intensive Care Med. 2022 Jan;48(1):130-132. doi: 10.1007/s00134-021-06560-6. Epub 2021 Oct 28. Intensive Care Med. 2022. PMID: 34713314 Free PMC article. No abstract available.
References
-
- Schädler D, Pausch C, Heise D, Meier-Hellmann A, Brederlau J, Weiler N, Marx G, Putensen C, Spies C, Jörres A, Quintel M, Engel C, Kellum JA, Kuhlmann MK. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial. PLoS ONE. 2017;12:e0187015. doi: 10.1371/journal.pone.0187015. - DOI - PMC - PubMed
-
- Supady A, Weber E, Rieder M, Lother A, Niklaus T, Zahn T, Frech F, Müller S, Kuhl M, Benk C, Maier S, Trummer G, Flügler A, Krüger K, Sekandarzad A, Stachon P, Zotzmann V, Bode C, Biever PM, Staudacher D, Wengenmayer T, Graf E, Duerschmied D. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial. Lancet Respir Med. 2021 doi: 10.1016/S2213-2600(21)00177-6. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
